Breast Cancer
Reports from P. Hopwood et al highlight recent research in breast cancer
Published in Cancer Weekly, June 24th, 2008
"Quality-of-Life (QL) data are increasingly relevant to trial results, but are often difficult to interpret and apply clinically; methods to address this problem are needed. Exploratory analyses were conducted using QL data from a recent phase III trial comparing front line gemcitabine plus paclitaxel (GT) versus paclitaxel (T) alone in patients with advanced breast cancer," researchers in Manchester, the United Kingdom report.
"The most troublesome symptom and toxicity items were identified. For each QL domain, associations and change over time were analyzed using clinically relevant data. The impact of tumor response and duration of therapy on QL outcomes was assessed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-06-24)
More Articles from Cancer Weekly
- Cure Lab, Inc.
A protein sequence associated with Huntington's disease may become life-saving vaccine component - Research
Outing the outliers: Strategy matches oncogene with subtype of prostate cancer - Cancer Gene Therapy
Reports outline cancer gene therapy research from Kaohsiung Medical University - Cancer Gene Therapy
Reports summarize cancer gene therapy research from University of Michigan, Medical Department - Cancer Gene Therapy
Scientists at Wuhan University describe research in cancer gene therapy - Cancer Gene Therapy
Study results from National Cancer Institute in the area of cancer gene therapy published - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
